Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Follow-Up Questions
Calithera Biosciences Inc (CALA) 的本益比是多少？
Calithera Biosciences Inc 的本益比是 0
Calithera Biosciences Inc 的 CEO 是誰？
Dr. Susan Molineaux 是 Calithera Biosciences Inc 的 President，自 2010 加入公司。
CALA 股票的價格表現如何？
CALA 的當前價格為 $0.0001，在上個交易日 decreased 了 0%。
Calithera Biosciences Inc 的主要業務主題或行業是什麼？
Calithera Biosciences Inc 屬於 Biotechnology 行業，該板塊是 Health Care
